Multiple sclerosis and botulinum toxin;Sclérose en plaques et toxine

Annales de Readaptation et de Medecine Physique

Volumn 46, Issue 6, 2003, Pages 299-302

  Lamotte, D ^a   Thoumie, P ^a  

^a HÔPITAL ROTHSCHILD   (France)

Author keywords

Botulinum toxin; Multiple sclerosis; Spasticity

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A;

DRUG INDICATION; HUMAN; JOINT FUNCTION; MEDLINE; MULTIPLE SCLEROSIS; MUSCLE SPASM; MUSCLE TONE; MUSCLE WEAKNESS; MYALGIA; REVIEW; SPASTICITY;

EID: 0042929917     PISSN: 01686054     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-6054(03)00106-5     Document Type: Article

References (13)

1. Bakheit AMO, Thiman AF, Ward AB, Poewe W, Wissel J, Muller J, et al. A randomized, double-blind, placebo-controlled, dose-ranging study to compare efficacity and safety of three doses of botulinum toxin A (Dysport) with placebo in upper limb spasticity after stroke. Stroke 2000;31:2402-6.
2. Burbaud P, Wiart L, Dubos JL, Gaujard E, Debeilleix X, Joseph PA, et al. A randomized, double-blind, placebo-controlled trial of botulinum toxin in the treatmant of spastic foot in hemiparetic patients. J Neurol Neurosurg Psychiatry 1996;61:265-9.
3. Borg-Stein J, Pine ZM, Miller JR, Brin MF. Botulinum toxin for the treatment of spasticity in multiple sclerosis: new observations. Am J Phys Med Rehabil 1993;72:364-8.
4. Dengler R, Neyer U, Wolhfarth K, Bettig U, Janzik HH. Local treatment of spastic drop foot. J Neurol 1992;239:375-8.
5. Grazko MA, Polo KB, Jabbari B. Botulinum toxin for spasticity muscle spasms, and rigidity. Neurology 1995;45:712-7.
6. Hesse S, Krajnik J, Luecke D, Jahnke MT, Gregoric M, Mauritz KH. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients. Stroke 1996;27:455-60.
7. Hyman N, Barnes M, Bhakta B, Czens A, Bakheit M, Kreczy-Kleedorfer B, et al. Botulinum toxin (Dysport®) treatment of hip adductor spasticity in multiple sclerosis: prospective, randomized, double blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psychiatry 2000;68:707-12.
8. Rontal E, Rontal M, Wald J, Rontal D. Botulinum toxin in the treatment of vocal fold paralysis associed with multiple sclerosis: a case report. Journal of Voice 1999;13(2):274-9.
9. Reiter F, Danni M, Lagalla G, Ceravollo G, Provincialli L. Low-dose botulinum toxin with ankle taping for the treatment of spatic equinovarus foot after stroke. Arch Phys Med Rehabil 1998;79:532-5.
10. Repka MX, Savino PJ, Reinecke RD. Treatment of acquired nystagmus with botulinum neurotoxin A. Arch Ophtalmol 1994;112(10): 1320-4.
11. Simpson DM. Botulinum toxin type A in the treatment of upper extremity spasticity. A randomized double placebo controlled trial. Neurology 1996;46:1306-10.
12. Smith SJ, Ellis E, White S, Moore AP. A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury. Clin Rehabil 2000;14:5-13.
13. Snow BJ, TsU JK, Bhatt MH, Varelas M, Hashimoto SA, Calne CB. Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol 1990;28:512-5.